| scholarly article | Q13442814 |
| P2093 | author name string | Masafumi Kakei | |
| Kei Nakajima | |||
| Toshitaka Muneyuki | |||
| Haruki Oshida | |||
| P2860 | cites work | The effect of obesity on health outcomes. | Q30379222 |
| Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-perio | Q33445235 | ||
| Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial | Q33446564 | ||
| A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery | Q33449829 | ||
| Fecal pancreatic elastase-1 levels in older individuals without known gastrointestinal diseases or diabetes mellitus | Q33803443 | ||
| Cystic fibrosis colonopathy | Q34027727 | ||
| Diagnosis of chronic pancreatitis: Functional testing. | Q34118008 | ||
| Pancreatic enzyme therapy for pancreatic exocrine insufficiency. | Q42140575 | ||
| A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency | Q42632093 | ||
| Do we need to exclude exocrine pancreatic insufficiency in IBS? | Q42919984 | ||
| Pancreatic enzyme replacement therapy: exocrine pancreatic insufficiency after gastrointestinal surgery. | Q42947552 | ||
| Cigarette smoking is independently associated with chronic pancreatitis | Q43120518 | ||
| Danish patients with chronic pancreatitis have a four-fold higher mortality rate than the Danish population | Q43206983 | ||
| EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency | Q43291217 | ||
| Fecal elastase-1 determination: 'gold standard' of indirect pancreatic function tests? | Q43758387 | ||
| Idiopathic pancreatitis associated with inflammatory bowel disease | Q43759629 | ||
| High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study | Q44618783 | ||
| Screening for pancreatic exocrine insufficiency in patients with diabetes mellitus | Q44700985 | ||
| Pancreatic insufficiency in adult celiac disease: do patients require long-term enzyme supplementation? | Q45048428 | ||
| Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). | Q45204627 | ||
| Administration of CREON® pancrelipase pellets via gastrostomy tube is feasible with no loss of gastric resistance or lipase activity: an in vitro study | Q45797776 | ||
| Efficacy of enzyme supplementation after surgery for chronic pancreatitis | Q46113742 | ||
| Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis | Q48386087 | ||
| Pancreatic enzyme replacement therapy in chronic pancreatitis | Q34118013 | ||
| Pancreatogenic diabetes: special considerations for management | Q34200573 | ||
| Pancreatic resection: effects on glucose metabolism | Q34245801 | ||
| Review article: coeliac disease, new approaches to therapy. | Q34253519 | ||
| The natural history of pain in alcoholic chronic pancreatitis | Q34503231 | ||
| Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study | Q34531167 | ||
| Consequences of smoking for body weight, body fat distribution, and insulin resistance | Q34768936 | ||
| Low serum amylase in association with metabolic syndrome and diabetes: A community-based study | Q35009097 | ||
| Lipase supplementation therapy: standards, alternatives, and perspectives | Q35033657 | ||
| Review article: Pancreatic function testing | Q35086837 | ||
| Is fibrosing colonopathy an immune mediated disease? | Q35255967 | ||
| Nutrition in patients with cystic fibrosis: a European Consensus | Q35908298 | ||
| Exocrine and endocrine pancreatic insufficiency after pancreatic surgery | Q35923063 | ||
| Treatment of Zollinger-Ellison syndrome | Q36285347 | ||
| The role of proton pump inhibitors in the treatment of Zollinger-Ellison syndrome | Q36376405 | ||
| Health risks associated with overweight and obesity | Q36742564 | ||
| Pancreatic enzyme pharmacotherapy | Q36837184 | ||
| Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis | Q37052832 | ||
| Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? | Q37069949 | ||
| Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review | Q37149541 | ||
| Tests of pancreatic exocrine function - clinical significance in pancreatic and non-pancreatic disorders. | Q37511247 | ||
| Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency | Q37608655 | ||
| Prevalence of dyslipidemia in adults with cystic fibrosis | Q37624200 | ||
| Pancreatitis in inflammatory bowel diseases | Q37678130 | ||
| Pancreatic Exocrine Insufficiency: Diagnostic Evaluation and Replacement Therapy with Pancreatic Enzymes | Q37784957 | ||
| Pancrelipase for pancreatic disorders: An update | Q37827702 | ||
| Celiac disease and health-related quality of life | Q37839092 | ||
| Pancreatic exocrine insufficiency: diagnosis and treatment. | Q37842755 | ||
| Pancreatic enzyme products: digesting the changes | Q37871722 | ||
| The role of fecal elastase-1 in detecting exocrine pancreatic disease | Q37883016 | ||
| Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes? | Q37913052 | ||
| Pancreatic enzyme therapy | Q37929594 | ||
| The insulin-pancreatic acinar axis | Q38152927 | ||
| Enzyme treatment after gastrointestinal surgery | Q40773850 | ||
| Incidence of alcoholic chronic pancreatitis in Copenhagen | Q41461145 | ||
| Association of chronic alcoholic liver and pancreatic disease: a prospective study | Q41507287 | ||
| Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis | Q42022559 | ||
| Epidemiological study of pancreatic diabetes in Japan in 2005: a nationwide study. | Q51141816 | ||
| Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. | Q51485588 | ||
| Pathogenesis of fibrosing colonopathy: the role of methacrylic acid copolymer. | Q51999787 | ||
| Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency. | Q52848817 | ||
| Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms? | Q52854508 | ||
| Coeliac disease | Q56094829 | ||
| Exocrine pancreatic function in patients with end-stage renal disease | Q56779266 | ||
| Prevalence and determinants of exocrine pancreatic insufficiency among older adults: Results of a population-based study | Q57192560 | ||
| Prevalence of Pancreatic Insufficiency in Inflammatory Bowel Diseases. Assessment by Fecal Elastase-1 | Q57971998 | ||
| Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution | Q58168549 | ||
| Iatrogenic hyperuricemia in children with cystic fibrosis | Q67418634 | ||
| Exocrine pancreatic function in chronic liver diseases | Q67680935 | ||
| Changes in pancreatic exocrine secretion with age: pancreatic exocrine secretion does decrease in the elderly | Q67885559 | ||
| Pancreatic function in chronic inflammatory bowel disease | Q68329624 | ||
| Exocrine pancreatic secretion in the elderly | Q69053092 | ||
| Relations between Pancreatic Enzyme Outputs and Malabsorption in Severe Pancreatic Insufficiency | Q69496537 | ||
| Functional reserve capacity of the exocrine pancreas | Q69662143 | ||
| Regulation of pancreatic acinar cell insulin receptors by insulin | Q70372222 | ||
| Alterations of exocrine pancreas in end-stage renal disease. Do they reflect a clinically relevant uremic pancreopathy? | Q70823758 | ||
| Pancreatic insufficiency in celiac disease is not dependent on nutritional status | Q72714111 | ||
| The insulin resistance syndrome in smokers is related to smoking habits | Q72858524 | ||
| The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet | Q73403963 | ||
| Cigarette smoking increases the risk of pancreatic calcification in late-onset but not early-onset idiopathic chronic pancreatitis | Q74279279 | ||
| Medical nutrition therapy for cystic fibrosis: beyond pancreatic enzyme replacement therapy | Q79972446 | ||
| The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis | Q79989894 | ||
| Chronic pancreatitis | Q80231426 | ||
| [Nutrition, cystic fibrosis and the digestive tract] | Q81804066 | ||
| Efficacy of a novel pancreatic enzyme product, EUR-1008 (Zenpep), in patients with exocrine pancreatic insufficiency due to chronic pancreatitis | Q83462341 | ||
| Pancreatic enzyme supplementation for patients receiving enteral feeds | Q83915437 | ||
| Efficacy and tolerability of Creon for Children in infants and toddlers with pancreatic exocrine insufficiency caused by cystic fibrosis: an open-label, single-arm, multicenter study | Q84075514 | ||
| Efficacy and safety of PANCREAZE® for treatment of exocrine pancreatic insufficiency due to cystic fibrosis | Q84244338 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancrelipase | Q7130425 |
| P304 | page(s) | 77-91 | |
| P577 | publication date | 2012-07-19 | |
| P1433 | published in | Core Evidence | Q5170161 |
| P1476 | title | Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency | |
| P478 | volume | 7 |
| Q51311767 | COMPARING THE ENZYME REPLACEMENT THERAPY COST IN POST PANCREATECTOMY PATIENTS DUE TO PANCREATIC TUMOR AND CHRONIC PANCREATITIS. |
| Q64980440 | Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency. |
| Q34386682 | Diagnosis and treatment of pancreatic exocrine insufficiency |
| Q93108152 | Endoscopic Ultrasound Findings in Patients Diagnosed with Exocrine Pancreatic Insufficiency by Low Fecal Elastase-1 |
| Q45914147 | Less common etiologies of exocrine pancreatic insufficiency. |
| Q26861371 | Nutrition in chronic pancreatitis |
| Q92678712 | Pancreatic Exocrine Insufficiency as a Complication of Gastrointestinal Surgery and the Impact of Pancreatic Enzyme Replacement Therapy |
| Q30457747 | Pancreatic enzyme replacement therapy during pancreatic insufficiency |
| Q53437793 | Pancreatic enzymes prepared in bicarbonate solution for administration through enteral feeding tubes. |
| Q39185556 | Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test. |
| Q42322542 | Practical guide to exocrine pancreatic insufficiency - Breaking the myths |
| Q47652853 | The role of complementary and alternative medicine for pancreatic disorders |
| Q93001640 | Which factors determine exocrine pancreatic dysfunction in diabetes mellitus? |
Search more.